The treatment of benign prostatic hyperplasia: a glimpse into the future.
The treatment of BPH has changed dramatically over the last decade. Industry has recognized the potential market for BPH therapies. Urologists have accepted and embrace the development of alternative treatment strategies. The combined resources and talents of industry and academic urology will lead to exciting future advances in this field. The optimal treatment of BPH requires not only new technology but a better understanding of the pathophysiology and natural history of this disease. Urologists are presently engaged in studies to better define these fundamental aspects of the disease process. The end result of these investigative efforts will be to the advantage of patients afflicted with BPH.
Lepor
H
H
Department of Urology, New York University School of Medicine New York, USA.
D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*